How big is the High Flow Nasal Cannula Market?
According to 6Wresearch internal database and industry insights, the Global High-Flow Nasal Cannula Market was valued at USD 5.2 Billion in 2024 and is expected to reach USD 7.8 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The market is witnessing steady expansion, driven by increasing respiratory disorders, rising ICU admissions, and technological advancements in non-invasive oxygen therapy.
Key Growth Drivers of the High Flow Nasal Cannula Market
- Rising incidence of chronic respiratory diseases such as COPD and asthma
- Growing geriatric population with higher susceptibility to pulmonary conditions
- Increased use of HFNC systems in ICUs and emergency settings for oxygen therapy
- Technological innovations enhancing humidification and temperature control
- Adoption of HFNC in neonatal and pediatric care for better oxygen delivery outcomes
High Flow Nasal Cannula Market Trends
The high flow nasal cannula market is growing with hospitals and clinics increasingly adopting high flow systems for efficient non-invasive oxygen therapy. Demand for systems with integrated humidifiers and temperature control is rising to improve patient comfort and airway health. Portable and compact HFNC devices are gaining traction in home care and ambulatory care settings. The integration of monitoring features for oxygen flow rate and saturation tracking is enhancing usability and treatment accuracy. There is also a shift toward disposable and hygienic consumables to ensure safety and infection control in clinical settings.
Emerging Developments in the High Flow Nasal Cannula Market
Technological advancements are leading to the development of HFNC devices with smart flow regulation precision oxygen control and user-friendly interfaces. Manufacturers are introducing high-efficiency humidification systems that maintain mucosal integrity during prolonged therapy. Pediatric and neonatal HFNC systems are evolving with more ergonomic designs and noise-reduction features. Integration with telemonitoring platforms is helping clinicians remotely track respiratory parameters. Strategic partnerships between device manufacturers and hospitals are helping expand product reach and customization based on clinical needs.
Major Companies in the High Flow Nasal Cannula Market
- Fisher and Paykel Healthcare Corporation Limited
- Vapotherm Inc
- ResMed Inc
- Becton Dickinson and Company BD
- Teleflex Incorporated
- Koninklijke Philips NV
- Hamilton Medical AG
- Smiths Medical ICU Medical
- GE Healthcare
- Medline Industries LP
How Big Is the High Flow Nasal Cannula Market: FAQs
The HFNC market was valued at USD 6.4 billion in 2024.
It is projected to grow at a CAGR of 6.9% from 2025 to 2031.
Critical care respiratory therapy emergency medicine neonatal care and home healthcare.
Increasing respiratory illnesses aging population and advances in oxygen delivery systems.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com